▶ 調査レポート

在宅及び代替場所点滴療法の世界市場 2020年

• 英文タイトル:Global Home and Alternate Site Infusion Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。在宅及び代替場所点滴療法の世界市場 2020年 / Global Home and Alternate Site Infusion Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201115588資料のイメージです。• レポートコード:GIR201115588
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、在宅及び代替場所点滴療法の世界市場を調査対象にし、在宅及び代替場所点滴療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(化学療法、抗感染症療法、免疫療法、一般看護サービス、その他)、用途別分析(家庭、外来点滴センター、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Option Care Health、PharMerica、HCA Healthcare、Coram CVS、Accredo Health、UnitedHealth Group、CHI Health、McLaren、Cleveland Clinic
・企業別売上、市場シェア
・在宅及び代替場所点滴療法の地域別市場分析
・在宅及び代替場所点滴療法の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・在宅及び代替場所点滴療法のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・在宅及び代替場所点滴療法のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・在宅及び代替場所点滴療法の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・在宅及び代替場所点滴療法の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・在宅及び代替場所点滴療法の種類別市場規模2015-2020:化学療法、抗感染症療法、免疫療法、一般看護サービス、その他
・在宅及び代替場所点滴療法の用途別市場規模2015-2020:家庭、外来点滴センター、その他
・在宅及び代替場所点滴療法の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The Home and Alternate Site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Home and Alternate Site Infusion Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Home and Alternate Site Infusion Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Home and Alternate Site Infusion Therapy market has been segmented into:
Chemotherapy
Anti-infective Therapies
Immune Therapy
General Nursing Services
Others

By Application, Home and Alternate Site Infusion Therapy has been segmented into:
Residential
Ambulatory Infusion Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Home and Alternate Site Infusion Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Home and Alternate Site Infusion Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Home and Alternate Site Infusion Therapy market.

The report offers in-depth assessment of the growth and other aspects of the Home and Alternate Site Infusion Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Home and Alternate Site Infusion Therapy Market Share Analysis
Home and Alternate Site Infusion Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Home and Alternate Site Infusion Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Home and Alternate Site Infusion Therapy sales, revenue and market share for each player covered in this report.

The major players covered in Home and Alternate Site Infusion Therapy are:
Option Care Health
PharMerica
HCA Healthcare
Coram CVS
Accredo Health
UnitedHealth Group
CHI Health
McLaren
Cleveland Clinic
Among other players domestic and global, Home and Alternate Site Infusion Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Home and Alternate Site Infusion Therapy Market Overview
1.1 Product Overview and Scope of Home and Alternate Site Infusion Therapy
1.2 Classification of Home and Alternate Site Infusion Therapy by Type
1.2.1 Global Home and Alternate Site Infusion Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Anti-infective Therapies
1.2.5 Immune Therapy
1.2.6 General Nursing Services
1.2.7 Others
1.3 Global Home and Alternate Site Infusion Therapy Market by Application
1.3.1 Overview: Global Home and Alternate Site Infusion Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Residential
1.3.3 Ambulatory Infusion Centers
1.3.4 Others
1.4 Global Home and Alternate Site Infusion Therapy Market by Regions
1.4.1 Global Home and Alternate Site Infusion Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Home and Alternate Site Infusion Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Home and Alternate Site Infusion Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Home and Alternate Site Infusion Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Home and Alternate Site Infusion Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Home and Alternate Site Infusion Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Home and Alternate Site Infusion Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Option Care Health
2.1.1 Option Care Health Details
2.1.2 Option Care Health Major Business
2.1.3 Option Care Health SWOT Analysis
2.1.4 Option Care Health Product and Services
2.1.5 Option Care Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 PharMerica
2.2.1 PharMerica Details
2.2.2 PharMerica Major Business
2.2.3 PharMerica SWOT Analysis
2.2.4 PharMerica Product and Services
2.2.5 PharMerica Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 HCA Healthcare
2.3.1 HCA Healthcare Details
2.3.2 HCA Healthcare Major Business
2.3.3 HCA Healthcare SWOT Analysis
2.3.4 HCA Healthcare Product and Services
2.3.5 HCA Healthcare Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Coram CVS
2.4.1 Coram CVS Details
2.4.2 Coram CVS Major Business
2.4.3 Coram CVS SWOT Analysis
2.4.4 Coram CVS Product and Services
2.4.5 Coram CVS Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Accredo Health
2.5.1 Accredo Health Details
2.5.2 Accredo Health Major Business
2.5.3 Accredo Health SWOT Analysis
2.5.4 Accredo Health Product and Services
2.5.5 Accredo Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 UnitedHealth Group
2.6.1 UnitedHealth Group Details
2.6.2 UnitedHealth Group Major Business
2.6.3 UnitedHealth Group Product and Services
2.6.4 UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 CHI Health
2.7.1 CHI Health Details
2.7.2 CHI Health Major Business
2.7.3 CHI Health Product and Services
2.7.4 CHI Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 McLaren
2.8.1 McLaren Details
2.8.2 McLaren Major Business
2.8.3 McLaren Product and Services
2.8.4 McLaren Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cleveland Clinic
2.9.1 Cleveland Clinic Details
2.9.2 Cleveland Clinic Major Business
2.9.3 Cleveland Clinic Product and Services
2.9.4 Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Home and Alternate Site Infusion Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Home and Alternate Site Infusion Therapy Players Market Share
3.2.2 Top 10 Home and Alternate Site Infusion Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Home and Alternate Site Infusion Therapy Revenue and Market Share by Regions
4.2 North America Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
5 North America Home and Alternate Site Infusion Therapy Revenue by Countries
5.1 North America Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
5.2 USA Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
6 Europe Home and Alternate Site Infusion Therapy Revenue by Countries
6.1 Europe Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
6.2 Germany Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.4 France Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Countries
7.1 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
7.2 China Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.5 India Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
8 South America Home and Alternate Site Infusion Therapy Revenue by Countries
8.1 South America Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
8.2 Brazil Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Home and Alternate Site Infusion Therapy by Countries
9.1 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Home and Alternate Site Infusion Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Anti-infective Therapies Revenue Growth Rate (2015-2025)
10.5 Immune Therapy Revenue Growth Rate (2015-2025)
10.6 General Nursing Services Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Home and Alternate Site Infusion Therapy Market Segment by Application
11.1 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Application (2015-2020)
11.2 Home and Alternate Site Infusion Therapy Market Forecast by Application (2019-2024)
11.3 Residential Revenue Growth (2015-2020)
11.4 Ambulatory Infusion Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Home and Alternate Site Infusion Therapy Market Size Forecast (2021-2025)
12.1 Global Home and Alternate Site Infusion Therapy Market Size Forecast (2021-2025)
12.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Regions (2021-2025)
12.3 North America Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
12.6 South America Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Home and Alternate Site Infusion Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Home and Alternate Site Infusion Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Home and Alternate Site Infusion Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Option Care Health Corporate Information, Location and Competitors
Table 7. Option Care Health Home and Alternate Site Infusion Therapy Major Business
Table 8. Option Care Health Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Option Care Health SWOT Analysis
Table 10. Option Care Health Home and Alternate Site Infusion Therapy Product and Solutions
Table 11. Option Care Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. PharMerica Corporate Information, Location and Competitors
Table 13. PharMerica Home and Alternate Site Infusion Therapy Major Business
Table 14. PharMerica Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2018-2019)
Table 15. PharMerica SWOT Analysis
Table 16. PharMerica Home and Alternate Site Infusion Therapy Product and Solutions
Table 17. PharMerica Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. HCA Healthcare Corporate Information, Location and Competitors
Table 19. HCA Healthcare Home and Alternate Site Infusion Therapy Major Business
Table 20. HCA Healthcare Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 21. HCA Healthcare SWOT Analysis
Table 22. HCA Healthcare Home and Alternate Site Infusion Therapy Product and Solutions
Table 23. HCA Healthcare Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Coram CVS Corporate Information, Location and Competitors
Table 25. Coram CVS Home and Alternate Site Infusion Therapy Major Business
Table 26. Coram CVS Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Coram CVS SWOT Analysis
Table 28. Coram CVS Home and Alternate Site Infusion Therapy Product and Solutions
Table 29. Coram CVS Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Accredo Health Corporate Information, Location and Competitors
Table 31. Accredo Health Home and Alternate Site Infusion Therapy Major Business
Table 32. Accredo Health Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Accredo Health SWOT Analysis
Table 34. Accredo Health Home and Alternate Site Infusion Therapy Product and Solutions
Table 35. Accredo Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. UnitedHealth Group Corporate Information, Location and Competitors
Table 37. UnitedHealth Group Home and Alternate Site Infusion Therapy Major Business
Table 38. UnitedHealth Group Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 39. UnitedHealth Group SWOT Analysis
Table 40. UnitedHealth Group Home and Alternate Site Infusion Therapy Product and Solutions
Table 41. UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. CHI Health Corporate Information, Location and Competitors
Table 43. CHI Health Home and Alternate Site Infusion Therapy Major Business
Table 44. CHI Health Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 45. CHI Health SWOT Analysis
Table 46. CHI Health Home and Alternate Site Infusion Therapy Product and Solutions
Table 47. CHI Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. McLaren Corporate Information, Location and Competitors
Table 49. McLaren Home and Alternate Site Infusion Therapy Major Business
Table 50. McLaren Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 51. McLaren SWOT Analysis
Table 52. McLaren Home and Alternate Site Infusion Therapy Product and Solutions
Table 53. McLaren Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Cleveland Clinic Corporate Information, Location and Competitors
Table 55. Cleveland Clinic Home and Alternate Site Infusion Therapy Major Business
Table 56. Cleveland Clinic Home and Alternate Site Infusion Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Cleveland Clinic SWOT Analysis
Table 58. Cleveland Clinic Home and Alternate Site Infusion Therapy Product and Solutions
Table 59. Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) by Players (2015-2020)
Table 61. Global Home and Alternate Site Infusion Therapy Revenue Share by Players (2015-2020)
Table 62. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Regions (2015-2020)
Table 64. North America Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
Table 65. North America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 66. Europe Home and Alternate Site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Home and Alternate Site Infusion Therapy Revenue by Countries (2015-2020)
Table 69. South America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Table 72. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) by Type (2015-2020)
Table 73. Global Home and Alternate Site Infusion Therapy Revenue Share by Type (2015-2020)
Table 74. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Type (2021-2025)
Table 75. Global Home and Alternate Site Infusion Therapy Revenue by Application (2015-2020)
Table 76. Global Home and Alternate Site Infusion Therapy Revenue Share by Application (2015-2020)
Table 77. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Application (2021-2025)
Table 78. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Home and Alternate Site Infusion Therapy Picture
Figure 2. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Anti-infective Therapies Picture
Figure 5. Immune Therapy Picture
Figure 6. General Nursing Services Picture
Figure 7. Others Picture
Figure 8. Home and Alternate Site Infusion Therapy Revenue Market Share by Application in 2019
Figure 9. Residential Picture
Figure 10. Ambulatory Infusion Centers Picture
Figure 11. Others Picture
Figure 12. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Home and Alternate Site Infusion Therapy Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2019
Figure 21. Global Top 10 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Regions (2015-2020)
Figure 25. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Regions in 2018
Figure 26. North America Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Europe Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 29. South America Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 31. North America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 32. North America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 33. USA Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Canada Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 36. Europe Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Home and Alternate Site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 38. Germany Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 39. UK Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 40. France Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Russia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Italy Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 45. China Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Japan Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Korea Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 48. India Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 50. South America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 51. South America Home and Alternate Site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 52. Brazil Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 57. UAE Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2015-2020)
Figure 60. Global Home and Alternate Site Infusion Therapy Revenue Share by Type (2015-2020)
Figure 61. Global Home and Alternate Site Infusion Therapy Revenue Share by Type in 2019
Figure 62. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Type (2021-2025)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Anti-infective Therapies Revenue Growth Rate (2015-2020)
Figure 65. Global Immune Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global General Nursing Services Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Home and Alternate Site Infusion Therapy Revenue Share by Application (2015-2020)
Figure 69. Global Home and Alternate Site Infusion Therapy Revenue Share by Application in 2019
Figure 70. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Application (2021-2025)
Figure 71. Global Residential Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Infusion Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Home and Alternate Site Infusion Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Home and Alternate Site Infusion Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 78. Europe Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 80. South America Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel